A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

NCT00710684 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

682

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: SB-742457 15mg
DRUG: SB-742457 35mg
DRUG: Placebo
DRUG: donepezil 5-10mg

Sponsor

GlaxoSmithKline